Core Points - The controlling shareholder, Yantai Zhongxing Biotechnology Co., Ltd., and its concerted party, Shanghai Tongyi Investment Management Co., Ltd., experienced a passive dilution of their shareholding due to convertible bond conversions and non-public stock issuance [1] - From August 7, 2025, to September 16, 2025, the information disclosure obligor reduced its shareholding by 1.579 million shares, accounting for 0.52% of the company's total share capital [1] - After the changes, Yantai Zhongxing holds 73.1258 million shares, representing 24.02% of the company, while Shanghai Tongyi Investment Management holds 2.981 million shares, representing 0.98% [1] - As of the report signing date, 4.4 million shares held by Yantai Zhongxing are under pledge [1] - There are no clear plans for further share increases or decreases by the information disclosure obligor and its concerted parties within the next 12 months [1]
中宠股份:上海通怡投资管理有限公司持股比例已降至0.98%